PELLICANO', Giovanni Francesco
 Distribuzione geografica
Continente #
NA - Nord America 11.258
EU - Europa 7.807
AS - Asia 6.536
SA - Sud America 2.931
AF - Africa 191
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 9
Totale 28.743
Nazione #
US - Stati Uniti d'America 11.024
SG - Singapore 2.903
BR - Brasile 2.595
IT - Italia 1.800
IE - Irlanda 1.783
CN - Cina 1.593
SE - Svezia 1.390
HK - Hong Kong 969
DE - Germania 575
PL - Polonia 540
VN - Vietnam 389
UA - Ucraina 359
FI - Finlandia 278
RU - Federazione Russa 263
GB - Regno Unito 230
FR - Francia 222
AR - Argentina 128
IN - India 117
AT - Austria 99
CA - Canada 99
MX - Messico 84
BD - Bangladesh 71
TR - Turchia 71
IQ - Iraq 66
EC - Ecuador 63
ZA - Sudafrica 61
ID - Indonesia 56
NL - Olanda 48
BE - Belgio 46
MA - Marocco 41
UZ - Uzbekistan 41
ES - Italia 38
PK - Pakistan 37
VE - Venezuela 35
CO - Colombia 32
JP - Giappone 29
PY - Paraguay 21
CL - Cile 19
CI - Costa d'Avorio 18
CZ - Repubblica Ceca 17
PE - Perù 17
LT - Lituania 16
AE - Emirati Arabi Uniti 15
AZ - Azerbaigian 15
JO - Giordania 15
KR - Corea 15
UY - Uruguay 15
AL - Albania 14
LV - Lettonia 12
NP - Nepal 12
DZ - Algeria 11
EG - Egitto 11
IR - Iran 11
TH - Thailandia 11
BG - Bulgaria 10
CH - Svizzera 10
DO - Repubblica Dominicana 10
JM - Giamaica 10
KE - Kenya 10
KG - Kirghizistan 10
PT - Portogallo 10
AU - Australia 9
KZ - Kazakistan 9
MY - Malesia 9
TN - Tunisia 9
EU - Europa 8
RO - Romania 8
SN - Senegal 8
BH - Bahrain 7
HN - Honduras 7
PA - Panama 7
RS - Serbia 7
GE - Georgia 6
IL - Israele 6
LK - Sri Lanka 6
OM - Oman 6
SA - Arabia Saudita 6
BO - Bolivia 5
CR - Costa Rica 5
DK - Danimarca 5
GR - Grecia 5
LB - Libano 5
NG - Nigeria 5
AM - Armenia 4
GH - Ghana 4
GT - Guatemala 4
NO - Norvegia 4
TT - Trinidad e Tobago 4
BF - Burkina Faso 3
BN - Brunei Darussalam 3
BW - Botswana 3
BY - Bielorussia 3
KW - Kuwait 3
LA - Repubblica Popolare Democratica del Laos 3
LU - Lussemburgo 3
MK - Macedonia 3
PH - Filippine 3
PS - Palestinian Territory 3
SY - Repubblica araba siriana 3
TW - Taiwan 3
Totale 28.714
Città #
Dublin 1.779
Dallas 1.622
Chandler 1.402
Singapore 1.346
Ashburn 1.145
Hong Kong 966
Jacksonville 875
Nyköping 764
Beijing 721
Warsaw 526
Princeton 431
Dearborn 416
Messina 375
Des Moines 262
Medford 258
Los Angeles 256
Ann Arbor 226
The Dalles 213
New York 196
São Paulo 190
Boardman 162
Cambridge 154
Munich 146
Buffalo 134
Redondo Beach 128
Ho Chi Minh City 111
Rome 111
Wilmington 98
Palermo 93
Jinan 89
Milan 87
Dong Ket 85
Moscow 82
Rio de Janeiro 79
Helsinki 76
Hanoi 75
Nuremberg 73
Catania 70
San Mateo 65
Belo Horizonte 64
Tianjin 62
Woodbridge 60
Houston 59
Nanjing 54
Shenyang 54
Lancaster 51
Vienna 50
Turku 49
Brasília 48
Brussels 46
Curitiba 43
Bremen 42
Pune 42
Brooklyn 40
Santa Clara 40
Tashkent 38
Porto Alegre 35
Johannesburg 34
Seattle 33
Frankfurt am Main 32
Guangzhou 31
Zhengzhou 30
Hebei 29
Jakarta 28
Ningbo 28
Denver 27
Haikou 27
Montreal 27
Atlanta 26
Campinas 26
Salvador 25
Tokyo 25
Caltagirone 24
Chennai 24
Goiânia 24
Guarulhos 24
Hangzhou 24
Mexico City 24
Norwalk 24
Ottawa 24
Ribeirão Preto 24
Stockholm 24
Baghdad 23
Guayaquil 23
San Francisco 23
Taizhou 23
Toronto 23
Boston 22
Falls Church 22
London 22
Naples 21
Phoenix 21
São José dos Campos 21
Fairfield 20
Manchester 20
Nanchang 20
Redwood City 20
Ankara 19
Istanbul 19
Manaus 19
Totale 17.813
Nome #
Very high pre-therapy viral load is a predictor of virological rebound in HIV-1-infected patients starting a modern first-line regimen 426
Awareness and perception of accurancy of the Undetectable=Untransmittable (U=U) message in people living with HIV/AIDS (PLWHA), in Italy and correlation with the level of confidence in reference physicians. 264
Wasting Syndrome (cachessia da HIV) in paziente confetto HBV-HCV 247
Durability of F/TAF-based regimens in a large cohort of PLWH seen of care in Italy 231
Impact of multi-drug resistance on mortality: a multi-cohort Italian study. 224
Anal cancer in people living with HIV: the importance of the screening and of early diagnosis 194
Breast cancer in women living with HIV 183
MALATTIE INFETTIVE E TROPICALI PER STUDENTI E MEDICI DI MEDICINA GENERALE 167
SINDROME INFIAMMATORIA DA IMMUNORICOSTITUZIONE (IRIS) 166
La terapia della brucellosi cronica con ciprofloxacina. Esperienze personali 161
AIDS E SISTEMA NERVOSO CENTRALE NEL PAZIENTE ADVANCED-NAÏVE 161
Bioenergetics of T Cell Activation and Death in HIV Type 1 Infection 156
Hepatitis C-related hepatocellular carcinoma: diagnostic and therapeutic management in HIV-patients. 151
Evaluation of HIV transmission cluster among natives and foreigners living Italy 149
Sindrome Retrovirale Acuta (SRA) in giovane omosessuale maschio 145
Kaposi’s sarcoma in HIV-infected patients in the era of new antiretrovirals 144
QUANTO I GIOVANI DELLA CITTA’ DI MESSINA CONOSCONO L’HIV/AIDS E LE MALATTIE SESSUALMENTE TRASMESSE? 143
Bacteremic meningitis due to Pasteurella multocida resistant to first line antibiotic therapy 141
Danno ipossico in linfociti T periferici di soggetti affetti da HIV/AIDS. 134
Epidemiologia delle farmacoresistenze di HIV nella regione Sicilia 134
Anxiety disorders and adherence to HAART 133
Sinus bradycardia in a patient with bacterial meningitis in therapy with IVIg: a case report 133
Alterazioni della membrana plasmatica in linfociti del sangue periferico di soggetti affetti da infezione da HIV/AIDS 132
Intracellular accumulation of cell cycle regulatory proteins and nucleolin re-localization are associated with pre-lethal ultrastructural lesions in circulating T lymphocytesThe HIV-induced cell cycle dysregulation revisited 131
La vaccinazione del soggetto HIV+: l’esperienza di una Azienda Ospedaliera Universitaria del Sud Italia 130
Aspetti clinico-epidemiologici della spondilodiscite brucellare 130
Neurotoxoplasmosi in soggetto HIV positivo “advanced naive”. Segnalazione di caso clinico 129
APPLICAZIONI INNOVATIVE PER LA DIAGNOSTICA DELL'INFEZIONE DA HIV 129
Circulating angiopoietin‑like protein 2 levels are associated with decreased renal function in HIV+ subjects on cART: A potential marker of kidney disease 128
Knowledge of sexually transmitted infections and risky behaviours: a survey among high school and university students 128
Sindrome di Castelman in paziente affetto da HIV e con sospetto Sarcoma di Kaposi. 128
DANNO IPOSSICO IN LINFOCITI T CIRCOLANTI DI PAZIENTI HIV+: RUOLO DELLA FIBROSI LINFONODALE. 125
Cancer screening in HIV-infected patients: early diagnosis in a high-risk population 125
48 Week efficacy of first line antiretroviral treatments for hiv infection in 1998 and 2006: preliminary results of a multicentric investigation 121
DISFUNZIONE MITOCONDRIALE IN LINFOCITI T CIRCOLANTI DI PAZIENTI HIV+. 121
Epidemiologia delle farmacoresistenza di HIV nella Regione Sicilia. 120
An evaluation of the burden of invasive Enterococcal infection in a large university hospital 120
Bone disease in HIV infection: an overview of pathogenesis, clinical manifestations and treatment 120
DANNO IPOSSICO IN LINFOCITI T PERIFERICI DI SOGGETTI AFFETTI DA HIV/AIDS. 119
Assistenza alla persona con HIV/AIDS 119
Non-AIDS defining cancers: a comprehensive update on diagnosis and management 119
A proposito di una osservazione di sindrome di Loffler in corso di ascaridiasi 118
Nucleolin relocalization associated top re-lethal alterations of T cell morphology: redefining death in HIV infection 118
Real-life efficacy and satisfaction of long-acting ART CabotegravirRilpivirine in HIV-infected individuals 117
19. Nostre esperienze con ciprofloxacina nella terapia della brucellosi acuta 117
ASSISTENZA ALLA PERSONA CON DISTURBI IMMUNO-MEDIATI 117
Impact of the COVID-19 pandemic on HPV vaccination coverage in the general population and in PLWHs 116
Nuovi regimi di terapia: l’utilizzo rationale di nuovi farmaci e nuove strategie (regimi nuk-sparing) 116
FARMACORESISTENZE E LORO CORRELAZIONI IN PAZIENTI HIV-1+ 116
MASSIVA MORTE APOPTOTICA DI LINFOCITI T NEL SANGUE PERIFERICO DI SOGGETTI INFETTI DA HIV: CONSEGUENZE PATOLOGICO-CLINICHE 116
Malignant melanoma in HIV: epidemiology, pathogenesis and management 116
Prostate cancer in HIV-positive patients: a review of the literature 115
Acute pericarditis during early-diagnosed Brucellosis: a case report. 112
Kaposi’s Sarcoma and Psoriasis in a naïve HIV-positive patient: a case report 112
A proposito della immunoterapia attiva nella Brucellosi Cronica 111
La terza età della terapia antiretrovirale di combinazione 111
HIV and Colorectal Cancer. New Insights and Review of the Literature 111
Impact of the M184V/I Mutation on the Efficacy of Abacavir/Lamivudina/Dolutegravir Therapy in Human Immunodeficiency Virus Treatment-Experienced Patients. 111
Efficacy of COVID-19 Vaccination in People Living with HIV: A Public Health Fundamental Tool for the Protection of Patients and the Correct Management of Infection 109
IL TENOFOVIR NELLA TERAPIA ANTIRETROVIRALE: OSSERVAZIONI SULLA POSSIBILE NEFROTOSSICITA' DEL FARMACO 109
Sexual dysfunction and anxiety in HIV-1-infected males in Eastern Sicily. 108
FARMACOGENETICA NELLA PRATICA CLINICA IN UNA POPOLAZIONE SICILIANA HIV+ 107
Safety and tolerability of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil fumarate in a real life setting: data from surveillance cohort long-term toxicity antiretrovirals/antivirals (SCOLTA) project 107
Loco-Regional Treatments for Hepatocellular Carcinoma in People Living with HIV 107
La patologia intestinale e ruolo di Giardia Lamblia in soggetti HIV+ 106
Outbreak of Brucella melitensis infection in Eastern Sicily: risk factors, clinical characteristics and complication rate 106
Bone marrow biopsy findings in brucellosis patients with hematologic abnormalities: useful remarks. 105
Encefalopatia latente in corso di cirrosi alcoolica 104
96 Week Follow-Up of HIV-Infected Patients in Rescuewith Raltegravir Plus Optimized Backbone Regimens: A Multicentre Italian Experience 104
HCV elimination in persons living with HIV (PLWH): the NoCo (No Coinfection) study of the ICONA network 103
Pseudomonas aeruginosa detection in South Italy: an epidemiological survey 103
Carbon nanotubes and central nervous system: Environmental risks, toxicological aspects and future perspectives 102
Massiva morte apoptotica di linfociti T nel sangue periferico di soggetti infetti da HIV: conseguenze patologico-cliniche 102
Comparative neuropsychiatric toxicity profile of dolutegravir versus efavirenz versus other antiretroviral third drugs used either in first-line or switching antiretroviral therapies (ART): data from ICONA Foundation Study Cohort 102
Transmission mode associated with coronavirus disease 2019: a review 102
CASO CLINICO: PAZIENTE HIV/HCV e “INDULTO” 101
AIDS Dementia Complex in paziente Advanced Naïve 101
Epatite A: immunità e accettazione della profilassi vaccinale in una coorte siciliana di pazienti con infezione da HIV. Dati preliminari. 101
Management care improvement of people living with HIV: Definition of a targeted clinical pathway in a university hospital of south Italy 100
RUOLO DELLA TRANSGLUTAMINASI 2 NELL’INFEZIONE DA HIV. 99
EDITORIAL – IMPROVING ACCESS AND ADHERENCE TO SCREENING TESTS FOR CANCERS: A NEW, THOUGH OLD, CHALLENGE IN THE HIV EPIDEMICS 99
Comparative neuropsychiatric toxicity profile of dolutegravir (DGT)-based versus efavirenz (EFV)-based versus other recommend first-line antiretroviral therapies (ART): data from ICONA Foundation Study Cohort. 98
Factors Associated With Weight Gain in People Treated With Dolutegravir 98
La patologia intestinale e ruolo di Giardia Lamblia in soggetti HIV+. 97
Epidemiology of the new HIV infections in a large university hospital of Southern Italy: the importance of increasing the culture of the HIV screening test in the prevention of late diagnosis 97
Cytomegalovirus complicating Inflammatory Bowel Disease: Useful Remarks. 96
Health status and Quality of life in people living with HIV (PLWH): results from the ICONA cohort 96
HIV and Mediterranean Zoonoses: A Review of the Literature 95
Muscle symptoms and creatinine phosphokinase elevations in patients receveiving raltegravir in clinical practice: results from a multi center study 95
A proposito di un caso di meningoencefalite da 1isteria monocitogenes 94
Analisis of efficacy and tolerability of raltegravir based regimens by background therapy in salvage: a Mulcicentre Italian Experience. 94
Epidemiology of Klebsiella pneumoniae MDR during the years 2015-2017 in “G. Martino” University Hospital of Messina: preliminary data. 94
Management care improvement of people living with HIV: Definition of a targeted clinical pathway in a university hospital of south Italy 94
La determinazione della ciclina B e la tecnica "AgNOR" nel monitoraggio della terapia antiretrovirale: dati preliminari. 93
Treatment of chronic brucellosis with ciprofloxacin. Personal experience 93
Investigational drugs in HIV: Pros and cons of entry and fusion inhibitors (Review). 93
The new era of vaccines: the “nanovaccinology” 93
1605. Dual Therapy VS Triple Therapy in Experienced PLWH: a Multicentre One-Year Long Observational Study 92
Current fast methods for the identification of carbapenemase enzymes in clinical laboratory. 92
Physician attitudes and perceptions of complementary and alternative medicine (CAM): a multicentre italian study. 92
Totale 12.494
Categoria #
all - tutte 112.205
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 112.205


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.132 0 0 0 0 0 217 138 174 126 196 114 167
2021/20222.177 21 222 44 104 145 42 101 106 54 209 257 872
2022/20235.806 780 394 225 471 425 565 116 329 2.182 39 203 77
2023/20241.483 149 202 121 172 96 290 39 72 24 69 51 198
2024/20257.757 112 106 165 479 631 191 187 1.599 1.989 437 617 1.244
2025/20266.995 851 1.425 1.762 1.347 1.432 178 0 0 0 0 0 0
Totale 30.308